Fara beint í efnið
Landspítali Forsíða
Landspítali Forsíða

Landspítali

Vel sótt Vísindi á vordögum

16. apríl 2026

Þann 8.-9. apríl sl. fór fram sameiginleg vísindaráðstefna Landspítala og Háskóla Íslands, Vísindi á vordögum.

Dagskráin var margvísleg og þétt: fjórir fundarsalir voru teknir undir ráðstefnuna þar sem fjölmörg erindi voru haldin, 180 rannsóknir á sviði heilbrigðisvísinda kynntar og gestum boðið að taka þátt í 36 málstofum.

Hér er hægt að horfa á upptöku af fyrri degi ráðstefnunnar:

Hér er hægt að horfa á upptöku af síðari deginum:

Hægt er að smella beint á stök atriði í dagskrá í myndbandslýsingunni.

Afhentir voru 33 styrkir úr Vísindasjóði Landspítala. Fimm fengu Hvatningastyrki sem hljóðuðu upp á 6 milljónir hver á ári í þrjú ár en almennu styrkirnir, sem voru alls 27, hljóðuðu upp á 2 milljónir hver á ári í allt að þrjú ár.

Hvatningastyrki hlutu:

  • Hans Tómas Björnsson, yfirlæknir og prófessor: Role of the m6A system in regulating the testicular MHR and fertility (m6A-MHR-fertility)

  • Ingibjörg Gunnarsdóttir, prófessor: Infant consumption of commercial baby foods, gut microbiome and metabolomic profile from 12 months to 5 years of age

  • Jóhanna Gunnarsdóttir, sérfræðilæknir og prófessor: Unraveling placental malperfusion: From clinical patterns to translational solutions

  • Siggeir Fannar Brynjólfsson, náttúrufræðingur og dósent: Investigating Haploinsufficiency in Immune Cells of Healthy BRCA2-999del5 Mutation Carriers

  • Sigurdís Haraldsdóttir, yfirlæknir og prófessor: Pancreatic cancer screening in high-risk individuals

Almenna styrki hlutu:

  • Aðalgeir Arason: Search for mutations causing risk of breast cancer in a large non-BRCA1/BRCA2 family

  • Antoine Pierre Michel Elyn: Ensuring Quality of End-of-life Care in Iceland: on the way to build the Icelandic Palliative and End-of-life Care Registry (IPEC-R)

  • Auður Anna Aradóttir Pind: Adjuvant properties of chitosan

  • Brynjar Halldórsson: Excessive reassurance seeking as a maintenance factor in eating disorders

  • Bylgja Hilmarsdóttir: Culture of organoids from ovarian tissue samples

  • Einar Stefán Björnsson: A Randomized, Non-inferiority Trial Comparing 7-Day Versus 4-Week Esomeprazole Treatment in Patients with Unexplained Dyspepsia

  • Freyja Jónsdóttir: Development of a state-of-the-art knowledge repository on medication associated risks related to the causation, treatment and prevention of delirium in different patient – COMeD

  • Gabriele Boretti: L-PIPL enriched GelMA/HAMA hydrogel: in vitro validation of 3D bioprinted cartilage constructs in hypoxic, perfused environment

  • Gunnhildur Ásta Traustadóttir: Application of a 3D co-culture model for functional studies of affibody-based affinity proteins that activate the immune system

  • Gunnsteinn Ægir Haraldsson: Molecular population genomics and epidemiology of human infections in Iceland caused by Streptococcus dysgalactiae subspecies equisimilis

  • Gunnsteinn Ægir Haraldsson: Monitoring antibiotic resistant bacteria through wastewater in Reykjavík: A public health surveillance approach

  • Hallgerður Lind Kristjánsdóttir: Population based study on acute and chronic myeloid leukemia in Iceland, comparison with Sweden. Building and implementation of a quality registry for acute and chronic myeloid leukemia in Iceland.

  • Inga Rós Valgeirsdóttir: The Challenge of Managing Hyperglycaemia Detected During Pregnancy

  • Jóhanna Gunnarsdóttir: Optimizing Fetal Growth Assessment in Iceland: Comparison and Development of Reference Curves

  • Jón Þórir Óskarsson: Clonal B-lineage differentiation in IgM monoclonal gammopathies

  • Magnús Gottfreðsson: Respiratory microbiota dysbiosis in community-acquired pneumonia. A prospective case-control study of 1102 microbiomes using metagenomic sequencing

  • Martin Ingi Sigurðsson: Safe and effective medication use in Iceland -MedSafe

  • Ólafur Árni Sveinsson: Stroke in Iceland epidemiology, current treatment and outcome

  • Ólafur Skúli Indriðason: A population-based discontinuation cohort study assessing eGFR trajectories after stopping long-term lithium therapy

  • Paolo Gargiulo: SYN-TWIN SPINE: Synthetic Twin of the Human Spine via Multi-Material, Microstructurally Tuned 3D Printing

  • Paolo Gargiulo: Quantitative Evaluation Metrics for Early-Stage Parkinson’s Disease Using the BioVRSea Paradigm

  • Siggeir Fannar Brynjólfsson: The Immunopathogenesis of Breast Implant Illness

  • Sigríður Gunnarsdóttir: Health literacy of cancer survivors compared to the general population: Findings from the nationwide SURV-ICE cohort

  • Sigurdís Haraldsdóttir: The molecular evolution from a primary tumor to metastases in young women and BRCA2+ carriers with breast cancer

  • Stefanía P. Bjarnarson: Overcoming immune tolerance in early life: defining adjuvant-driven pathways for enhanced vaccine efficacy

  • Þorvarður Jón Löve: Determining the Clinical Significance of Monoclonal Gammopathy of Undetermined Significance

  • Þórður Helgason: Electrode distribution for optimized target selectivity in electrical stimulation: A mathematical modelling approach

  • Þórunn Scheving Elíasdóttir: Quality of life, knowledge and nursing needs of outpatients with cirrhosis at Landspítali, the University Hospital of Iceland.

Frekari upplýsingar um Vísindi á vordögum má finna á heimasíðu ráðstefnunnar.